Hims & Hers Health, Inc. (HIMS): Price and Financial Metrics
HIMS Price/Volume Stats
| Current price | $6.29 | 52-week high | $12.34 |
| Prev. close | $6.36 | 52-week low | $4.01 |
| Day low | $6.24 | Volume | 2,028,100 |
| Day high | $6.54 | Avg. volume | 3,034,674 |
| 50-day MA | $7.09 | Dividend yield | N/A |
| 200-day MA | $8.56 | Market Cap | 1.33B |
HIMS Stock Price Chart Interactive Chart >
HIMS POWR Grades
- HIMS scores best on the Growth dimension, with a Growth rank ahead of 93.43% of US stocks.
- HIMS's strongest trending metric is Quality; it's been moving up over the last 177 days.
- HIMS's current lowest rank is in the Stability metric (where it is better than 6.99% of US stocks).
HIMS Stock Summary
- Price to trailing twelve month operating cash flow for HIMS is currently 49.59, higher than 92.98% of US stocks with positive operating cash flow.
- The ratio of debt to operating expenses for HIMS & HERS HEALTH INC is higher than it is for about just 4.86% of US stocks.
- As for revenue growth, note that HIMS's revenue has grown 90.16% over the past 12 months; that beats the revenue growth of 94.07% of US companies in our set.
- If you're looking for stocks that are quantitatively similar to HIMS & HERS HEALTH INC, a group of peers worth examining would be VEEE, CREX, AYTU, TOMZ, and ASUR.
- HIMS's SEC filings can be seen here. And to visit HIMS & HERS HEALTH INC's official web site, go to www.forhims.com.
HIMS Valuation Summary
- In comparison to the median Consumer Defensive stock, HIMS's price/sales ratio is 0% higher, now standing at 1.8.
- HIMS's price/sales ratio has moved NA NA over the prior 51 months.
Below are key valuation metrics over time for HIMS.
| Stock | Date | P/S | P/B | P/E | EV/EBIT |
|---|---|---|---|---|---|
| HIMS | 2023-09-22 | 1.8 | 4.0 | -27.0 | -25.8 |
| HIMS | 2023-09-21 | 1.8 | 4.0 | -27.4 | -26.3 |
| HIMS | 2023-09-20 | 1.8 | 4.1 | -27.8 | -26.6 |
| HIMS | 2023-09-19 | 1.9 | 4.1 | -28.0 | -26.9 |
| HIMS | 2023-09-18 | 1.9 | 4.2 | -28.5 | -27.3 |
| HIMS | 2023-09-15 | 1.9 | 4.2 | -28.3 | -27.2 |
HIMS's Quality Factors
The “Quality” component of the POWR Ratings focuses on 31 different factors of a companies fundamentals and operational strength. Here are some key insights as we drill into the specifics of these quality attributes.- HIMS has a Quality Grade of C, ranking ahead of 40.35% of graded US stocks.
- HIMS's asset turnover comes in at 1.028 -- ranking 21st of 81 Healthcare stocks.
- 500 - Internal server error
The table below shows HIMS's key quality metrics over time.
| Period | Asset Turnover | Gross Margin | ROIC |
|---|---|---|---|
| 2021-06-30 | 1.028 | 0.752 | -0.439 |
| 2021-03-31 | 0.917 | 0.744 | -0.393 |
| 2020-12-31 | 0.807 | 0.736 | -0.105 |
| 2020-09-30 | 0.521 | 0.723 | -0.059 |
| 2020-09-30 | 0.521 | 0.723 | -0.059 |
| 2020-09-30 | 0.521 | 0.723 | -0.059 |
Hims & Hers Health, Inc. (HIMS) Company Bio
Hims & Hers Health, Inc. provides health care software solutions. The Company offers multi-specialty telehealth platform that connects consumers to licensed healthcare providers, enabling them to access high-quality medical care for numerous conditions related to mental health, sexual health, dermatology, and primary care. Hims & Hers Health serves customers in the United States.
Latest HIMS News From Around the Web
Below are the latest news stories about HIMS & HERS HEALTH INC that investors may wish to consider to help them evaluate HIMS as an investment opportunity.
Rocket Stocks: 3 Investments Primed to Skyrocket by Year’s EndThree companies have thrived thanks to their innovative strategies and adaptability in the face of change. |
Hims & Hers Named on Fortune Media and Great Place to Work’s 2023 Best Workplaces in Health Care ListSAN FRANCISCO, September 06, 2023--Hims & Hers Health, Inc. ("Hims & Hers", NYSE: HIMS), the leading health and wellness platform, today announced Great Place To Work® and Fortune magazine named the company on the 2023 Fortune Best Workplaces in Health Care™ List. |
Today’s Biggest Pre-Market Stock Movers: 10 Top Gainers and Losers on TuesdayWe're starting off the day with a look at all of the biggest pre-market stock movers worth keeping an eye on for Tuesday! |
Moody's bank downgrades, Novavax, Hims & Hers, Olaplex: Trending stocksMoody's analysts have downgraded several small and mid-sized banks, while other banks remain on a downgrade watch over financial conditions. Novavax (NVAX) reports a surprise second-quarter profit tied to its COVID-19 vaccine. Health and wellness company Hims & Hers (HIMS) sees shares rise on a revenue beat and raising full-year guidance. Olaplex (OLPX) stock dips as retail sales plunge amid a demand slump. Yahoo Finance Live anchor Julie Hyman takes a look at several trending stocks in the morning trading session. |
Hims & Hers weight loss business to launch by end of 2023Hims & Hers to enter into lucrative weight loss market. |
HIMS Price Returns
| 1-mo | -6.26% |
| 3-mo | -33.09% |
| 6-mo | -38.99% |
| 1-year | 12.72% |
| 3-year | -46.47% |
| 5-year | N/A |
| YTD | -1.87% |
| 2022 | -2.14% |
| 2021 | -55.14% |
| 2020 | N/A |
| 2019 | N/A |
| 2018 | N/A |
Loading social stream, please wait...